Three years of treatment with minodronate in patients with postmenopausal osteoporosis

The objective of this study was to determine the safety and efficacy of long-term minodronate treatment in women with postmenopausal osteoporosis based on re-analysis of a phase III 2-year clinical trial with a 1-year extension. Women aged 55–80 years old with fragility fractures were enrolled and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagino, Hiroshi, Shiraki, Masataka, Fukunaga, Masao, Nakano, Tetsuo, Takaoka, Kunio, Ohashi, Yasuo, Nakamura, Toshitaka, Matsumoto, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396350/
https://www.ncbi.nlm.nih.gov/pubmed/22134624
http://dx.doi.org/10.1007/s00774-011-0332-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396350/
https://www.ncbi.nlm.nih.gov/pubmed/22134624
http://dx.doi.org/10.1007/s00774-011-0332-2

Ejemplares similares